COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 295: Articles 2941-2950  | Next

The antiviral potential of the antiandrogen enzalutamide and the viral-androgen interplay in seasonal coronaviruses
Ogunjinmi, O. D., Abdullahi, T., Somji, R.-A., Bevan, C. L., Barclay, W. S., Temperton, N. J., Brooke, G. N., Giotis, E. S.
10.1101/2023.11.25.568685 — Posted: 2023-11-27
Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection.
Lercher, A., Cheong, J.-G., Jiang, C., Hoffmann, H.-H., Ashbrook, A. W., Yin, Y. S., Quirk, C., DeGrace, E. J., Chiriboga, L., Rosenberg, B. R., Josefowicz, S. Z., Rice, C. M.
10.1101/2023.11.24.568354 — Posted: 2023-11-27
Isogenic iPSC-derived proximal and distal lung-on-chip models: Tissue- and virus-specific immune responses in human lungs
Yadav, S., Fujimoto, K., Takenaga, T., Takahashi, S., Muramoto, Y., Mikawa, R., Noda, T., Gotoh, S., Yokokawa, R.
10.1101/2023.11.24.568532 — Posted: 2023-11-24
Wastewater monitoring of SARS-CoV-2 gene for COVID-19 epidemiological surveillance in Tucuman Argentina
DArpino, M. C., Sineli, P. E., Goroso, G., Watanabe, W., Saavedra, L., Hebert, E. M., Martinez, A., Migliavacca, J., Gerstenfeld, S., Chahla, R. E., Bellomio, A., Albarracin, V. H.
10.1101/2023.11.22.23298851 — Posted: 2023-11-23
Quantitative susceptibility mapping at 7 Tesla in COVID-19: mechanistic and outcome associations
Rua, C., Raman, B., Rodgers, C. T., Newcombe, V. F. J., Manktelow, A., Chatfield, D. A., Sawcer, S. J., Outtrim, J. G., Lupson, V. C., Stamatakis, E. A., Williams, G. B., Clarke, W. T., Qiu, L., Ezra, M., McDonald, R., Clare, S., Cassar, M., Neubauer, S., Ersche, K. D., Bullmore, E. T., Menon, D. K., Pattinson, K., Rowe, J. B.
10.1101/2023.11.22.23298899 — Posted: 2023-11-23
Assessment of the effectiveness of required weekly COVID-19 surveillance antigen testing at a university
Ryan, C. W.
10.1101/2023.11.22.23298917 — Posted: 2023-11-23
Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
Inchauste, L., Nurtop, E., Bautista Machicado, L., Leigue Roth, Y., Lenz Gonzales, S., Herrera, M. L., Mina Villafan, K., Mamani Mamani, P., Ramos Espinoza, M., Pavel Suarez, J. C., Garcia Copa, J. C., Leigue Zabala, Y., Arancibia Cardozo, E., Gallian, P., de Lamballerie, X., Priet, S.
10.1101/2023.11.23.23298957 — Posted: 2023-11-23
Enhanced surface accessibility of SARS-CoV-2 Omicron spike protein due to an altered glycosylation profile
Wang, D., Zhang, Z., Baudys, J., Haynes, C. A., Osman, S. H., Zhou, B., Barr, J. R., Gumbart, J. C.
10.1101/2023.11.22.568381 — Posted: 2023-11-23
Assembly reactions of SARS-CoV-2 nucleocapsid protein with nucleic acid
Zhao, H., Syed, A. M., Khalid, M. M., Nguyen, A., Ciling, A., Wu, D., Yau, W.-M., Srinivasan, S., Esposito, D., Doudna, J. A., Piszczek, G., Ott, M., Schuck, P.
10.1101/2023.11.22.568361 — Posted: 2023-11-23
Predicting Antibody and ACE2 Affinity forSARS-CoV-2 BA.2.86 with In Silico ProteinModeling and Docking
Yasa, S. R., Guirales-Medrano, S., Jacob Machado, D., Ford, C. T., Janies, D. A.
10.1101/2023.11.22.568364 — Posted: 2023-11-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).